We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Showcases Automated Nucleic Acid Extraction Systems and Solutions

By LabMedica International staff writers
Posted on 25 Jul 2023

Jiangsu Bioperfectus Technologies Co. More...

, Ltd. (Shanghai, China) is showcasing its wide range of dependable solutions for meeting every laboratory's PCR needs at AACC 2023. The company is also highlighting its automatic nucleic acid extraction systems alongside its range of RUO products and raw materials for life science solutions.

Bioperfectus Total PCR Solution offers holistic products of extraction systems, extraction reagents, real-time PCR systems, and RT-PCR reagents. These products cover PCR detection workflow and assure the users with reassuring results by validated performance. Total PCR Solutions can improve operational and cost efficiency, optimize workflow and improve performance at every opportunity. At AACC 2023, Bioperfectus is also presenting its comprehensive range of PCR-related products and raw materials that exhibit excellent stability to ensure accurate and reliable experimental results.

Visitors to the Bioperfectus booth at AACC 2023 can get an early look at the company’s solutions designed to help address the present as well as future needs of laboratories. The company’s new SSNP-2000B nucleic acid extraction system being exhibited at the show integrates advanced technologies such as machine, electricity and computer software to enable the automatic nucleic acid extraction of a maximum of 32 samples at one time. In addition, the new SAW-48 in-vitro diagnostic medical device being highlighted at the show combines sample loading, nucleic acid purification, and PCR setup functions (PCR master mix preparation and nucleic acid pipetting) into one instrument. It has the same basic functions as SAW-96 but is smaller and lighter. Bioperfectus is also showcasing the STC-96A Plus Real-Time PCR System which is a more flexible, efficient and reliable breakthrough in real-time PCR analysis of gene expression and genetic variation. It allows users to apply two different PCR assays on just one instrument with separate-controlled programs.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd. 


New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Slide Scanner
VENTANA DP 600
New
Blood Gas and Chemistry Analysis System
Edan i500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.